These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18425965)

  • 1. Pentoxifylline for diabetic retinopathy.
    Lopes de Jesus CC; Atallah AN; Valente O; Moça Trevisani VF
    Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD006693. PubMed ID: 18425965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy.
    Lopes de Jesus CC; Atallah AN; Valente O; Moça Trevisani VF
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006695. PubMed ID: 18254110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single herbal medicine for diabetic retinopathy.
    Zhang HW; Zhang H; Grant SJ; Wan X; Li G
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD007939. PubMed ID: 30566763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure control for diabetic retinopathy.
    Do DV; Wang X; Vedula SS; Marrone M; Sleilati G; Hawkins BS; Frank RN
    Cochrane Database Syst Rev; 2015 Jan; 1():CD006127. PubMed ID: 25637717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser photocoagulation for proliferative diabetic retinopathy.
    Evans JR; Michelessi M; Virgili G
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD011234. PubMed ID: 25420029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
    Martinez-Zapata MJ; Martí-Carvajal AJ; Solà I; Pijoán JI; Buil-Calvo JA; Cordero JA; Evans JR
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008721. PubMed ID: 25418485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline for intermittent claudication.
    Broderick C; Forster R; Abdel-Hadi M; Salhiyyah K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD005262. PubMed ID: 33063850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
    Martinez-Zapata MJ; Salvador I; Martí-Carvajal AJ; Pijoan JI; Cordero JA; Ponomarev D; Kernohan A; Solà I; Virgili G
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD008721. PubMed ID: 36939655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions to increase attendance for diabetic retinopathy screening.
    Lawrenson JG; Graham-Rowe E; Lorencatto F; Burr J; Bunce C; Francis JJ; Aluko P; Rice S; Vale L; Peto T; Presseau J; Ivers N; Grimshaw JM
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012054. PubMed ID: 29333660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifylline for diabetic kidney disease.
    Shan D; Wu HM; Yuan QY; Li J; Zhou RL; Liu GJ
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006800. PubMed ID: 22336824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline for intermittent claudication.
    Salhiyyah K; Forster R; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA
    Cochrane Database Syst Rev; 2015 Sep; 9(9):CD005262. PubMed ID: 26417854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
    Virgili G; Menchini F; Murro V; Peluso E; Rosa F; Casazza G
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008081. PubMed ID: 21735421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentoxifylline for intermittent claudication.
    Salhiyyah K; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA
    Cochrane Database Syst Rev; 2012 Jan; 1():CD005262. PubMed ID: 22258961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Smith JM; Steel DH
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.